Comparison of the efficacy of sitagliptin 25mg and teneligliptin 20mg in patient with type2 diabetes and chronic kidney disease.
Not Applicable
Recruiting
- Conditions
- type2 diabetes meliitus
- Registration Number
- JPRN-UMIN000023243
- Lead Sponsor
- Department of Endocrinology and Metabolism University of Fukui Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patients of both drugs is contraindicated Pregnancy, patients in nursing Patients suffering from a severe disease requiring hospitalization Patients with anemia (Hb <10g / dl) Patients undergoing steroid therapy Patients attending physician was found to be inappropriate for any reason
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in blood glucose and HbA1c
- Secondary Outcome Measures
Name Time Method